The U.S. FDA has granted QuidelOrtho (QDEL) 510(k) clearance for the VITROS hs Troponin I Reagent Pack. The assay is intended for the quantitative measurement of cardiac troponin I in human plasma to aid in the diagnosis of myocardial infarction.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL: